<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9048660</article-id>
    <article-id pub-id-type="pmid">35244144</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btac139</article-id>
    <article-id pub-id-type="publisher-id">btac139</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Sequence Analysis</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Transgene-design: a web application for the design of mammalian transgenes</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Mühlhausen</surname>
          <given-names>Stefanie</given-names>
        </name>
        <aff><institution>Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath</institution>, Bath BA2 7AY, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1002-1054</contrib-id>
        <name>
          <surname>Hurst</surname>
          <given-names>Laurence D</given-names>
        </name>
        <xref rid="btac139-cor1" ref-type="corresp"/>
        <!--l.d.hurst@bath.a.c.uk-->
        <aff><institution>Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath</institution>, Bath BA2 7AY, <country country="GB">UK</country></aff>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Martelli</surname>
          <given-names>Pier Luigi</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btac139-cor1">To whom correspondence should be addressed. <email>l.d.hurst@bath.a.c.uk</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>01</day>
      <month>5</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-03-04">
      <day>04</day>
      <month>3</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>04</day>
      <month>3</month>
      <year>2022</year>
    </pub-date>
    <volume>38</volume>
    <issue>9</issue>
    <fpage>2626</fpage>
    <lpage>2627</lpage>
    <history>
      <date date-type="received">
        <day>13</day>
        <month>12</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>15</day>
        <month>2</month>
        <year>2022</year>
      </date>
      <date date-type="editorial-decision">
        <day>27</day>
        <month>2</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>02</day>
        <month>3</month>
        <year>2022</year>
      </date>
      <date date-type="corrected-typeset">
        <day>10</day>
        <month>3</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btac139.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>Transgene-design is a web application to help design transgenes for use in mammalian studies. It is predicated on the recent discovery that human intronless transgenes and native retrogenes can be expressed very effectively if the GC content at exonic synonymous sites is high. In addition, as exonic splice enhancers resident in intron containing genes may have different utility in intronless genes, these can be reduced or increased in density. Input can be a native gene or a commercially ‘optimised’ gene. The option to leave in the first intron and to protect or avoid other motifs is also permitted. </p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>Transgene-design is based on a ruby for rails platform. The application is available at <ext-link xlink:href="https://transgene-design.bath.ac.uk" ext-link-type="uri">https://transgene-design.bath.ac.uk</ext-link>. The code is available under GNU General Public License from GitHub (<ext-link xlink:href="https://github.com/smuehlh/transgenes" ext-link-type="uri">https://github.com/smuehlh/transgenes</ext-link>).</p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>European Research Council grant EvoGenMed</institution>
          </institution-wrap>
        </funding-source>
        <award-id>ERC-2014-ADG 669207</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="2"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction </title>
    <p>The average human gene is over 90% intron (<xref rid="btac139-B15" ref-type="bibr">Piovesan <italic toggle="yes">et al.</italic>, 2019</xref>), more than in most other species (<xref rid="btac139-B17" ref-type="bibr">Warnecke <italic toggle="yes">et al.</italic>, 2008</xref>). As a consequence, to make manageable transgenes (e.g. by gene synthesis) for experimentation or for gene therapy it is necessary to remove introns. Typically, however, the long first intron is often retained as this is necessary for robust gene expression (<xref rid="btac139-B8" ref-type="bibr">Le Hir <italic toggle="yes">et al.</italic>, 2003</xref>). Indeed, intronless transgenes are classically avoided as they express poorly (see e.g. <xref rid="btac139-B2" ref-type="bibr">Brinster <italic toggle="yes">et al.</italic>, 1988</xref>). To both save synthesis costs and to increase the CDS lengths that are stable via synthesis, it would be advantageous to be able to robustly express intronless transgenes. </p>
    <p>We recently observed that human intronless retrogenes have much higher GC content at synonymous sites compared to their intron containing parental genes (<xref rid="btac139-B9" ref-type="bibr">Mordstein <italic toggle="yes">et al.</italic>, 2020</xref>). Stimulated by this, we showed, using synthetic transgenes differing in synonymous GC content, that poor expression of intronless transgenes can be very effectively mitigated by increasing such GC content (<xref rid="btac139-B9" ref-type="bibr">Mordstein <italic toggle="yes">et al.</italic>, 2020</xref>). The effect is particular to the 5′ end of the gene (<xref rid="btac139-B9" ref-type="bibr">Mordstein <italic toggle="yes">et al.</italic>, 2020</xref>). The mechanism by which high GC rescues intronless transgenes is not fully resolved but relates in part to nuclear export control (<xref rid="btac139-B9" ref-type="bibr">Mordstein <italic toggle="yes">et al.</italic>, 2020</xref>; <xref rid="btac139-B12" ref-type="bibr">Palazzo <italic toggle="yes">et al.</italic>, 2012</xref>, <xref rid="btac139-B13" ref-type="bibr">2021</xref>; <xref rid="btac139-B20" ref-type="bibr">Zuckerman <italic toggle="yes">et al.</italic>, 2020</xref>), possibly as part of an evolved quality control system e.g. to filter out spurious non-coding transcripts (<xref rid="btac139-B12" ref-type="bibr">Palazzo <italic toggle="yes">et al.</italic>, 2012</xref>) or viral sequences (<xref rid="btac139-B10" ref-type="bibr">Mordstein <italic toggle="yes">et al.</italic>, 2021</xref>).</p>
    <p>The removal of introns also potentially comes with its own issues. Possibly because of the size and number of introns, humans have unusually high densities of exonic splice enhancers (ESEs) towards the ends of their exons (<xref rid="btac139-B4" ref-type="bibr">Fairbrother <italic toggle="yes">et al.</italic>, 2004a</xref>,<xref rid="btac139-B5" ref-type="bibr">b</xref>; <xref rid="btac139-B17" ref-type="bibr">Warnecke <italic toggle="yes">et al.</italic>, 2008</xref>; <xref rid="btac139-B18" ref-type="bibr">Wu <italic toggle="yes">et al.</italic>, 2015</xref>). These hexameric motifs attract SR proteins and in so doing direct the SR protein to an exon–intron junction to initiate splicing (<xref rid="btac139-B1" ref-type="bibr">Blencowe, 2000</xref>). In intronless human retrogenes rates of evolution are highest in proximity to the paralogous locations of exon–intron junctions in the intron containing parental gene (<xref rid="btac139-B14" ref-type="bibr">Parmley <italic toggle="yes">et al.</italic>, 2007</xref>). This is potentially consistent with selection to reduce ESE–SR protein attraction as splicing is deleterious in intronless genes although there was no evidence that ESEs were especially being degraded (<xref rid="btac139-B14" ref-type="bibr">Parmley <italic toggle="yes">et al.</italic>, 2007</xref>). Indeed, native human intronless genes retain ESEs and these remain under purifying selection suggesting non-splicing roles (<xref rid="btac139-B16" ref-type="bibr">Savisaar <italic toggle="yes">et al.</italic>, 2016</xref>). Preliminary data (unpublished) finds that modification of ESE density alters expression level, independent of GC effects, but at a potential cost to increased missplicing of the intronless transcript. Manipulation of ESE density may well be helpful for both intronless and single intron transgenes.</p>
    <p>In the above context, it is helpful, particularly for especially long CDS genes, to make effective intronless versions. We here describe a web application (<ext-link xlink:href="https://transgene-design.bath.ac.uk" ext-link-type="uri">https://transgene-design.bath.ac.uk</ext-link>) to (i) adjust GC content and (ii) to modify ESE density of intronless genes. It also permits the first intron to be retained if desired and important motifs to be protected or avoided.</p>
  </sec>
  <sec>
    <title>2 Features</title>
    <p>The application permits the user to upload a desired 5′ or 3′ sequence and an accompanying gene body. The gene can be input from a Genbank or fasta file (paste or upload). The user then has an option to enter ESE motifs via paste function, upload or use any one of five predefined sets. These are RESCUE-ESE (<xref rid="btac139-B4" ref-type="bibr">Fairbrother <italic toggle="yes">et al.</italic>, 2004a</xref>,<xref rid="btac139-B5" ref-type="bibr">b</xref>), ESR (<xref rid="btac139-B6" ref-type="bibr">Goren <italic toggle="yes">et al.</italic>, 2006</xref>), Ke-ESE400 (<xref rid="btac139-B7" ref-type="bibr">Ke <italic toggle="yes">et al.</italic>, 2011</xref>), PESE (<xref rid="btac139-B19" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic>, 2004</xref>) or the set of hexameric ESEs found in at least three of the four, INT3 (<xref rid="btac139-B3" ref-type="bibr">Caceres <italic toggle="yes">et al.</italic>, 2013</xref>). For further characterization and comparison of these sets, see <xref rid="btac139-B3" ref-type="bibr">Caceres <italic toggle="yes">et al.</italic> (2013)</xref>.</p>
    <p>The user can select to increase or decrease ESE content (see ‘more options’). In the latter case, the application identifies ESEs to be removed and does so in line with GC stipulations. In our experience it is possible to reduce ESE density but never to remove them entirely, which is likely to be beneficial (<xref rid="btac139-B16" ref-type="bibr">Savisaar <italic toggle="yes">et al.</italic>, 2016</xref>). The user can define motifs to be left intact or to not introduce (e.g. known miRNA binding sites).</p>
    <p>Finally, to adjust GC content the user can (i) opt to just adjust ESEs not GC (not recommended for most genes as GC3 is typically too low), (ii) match the GC at synonymous sites to that seen in 1 or 2 exon genes as a function of 5′ proximity, (iii) maximize GC or (iv) humanize (match human codon usage). For intronless genes we recommend either options 2 or 3. For genes retaining the first intron we recommend option 2.</p>
    <p>To match GC content to that seen in 1 or 2 exon genes, synonymous codons are scored to position-dependent codon favourability in human genes. Codon favourability is derived from a matrix of probabilities for the last nucleotide in a codon box (6-fold codon boxes being split into their respective 4-fold and 2-fold sub-boxes), fitted into curves as a function of position. Alternatively, GC content may be adjusted to position-independent, human codon usage obtained from the Codon Usage Database (<xref rid="btac139-B11" ref-type="bibr">Nakamura <italic toggle="yes">et al.</italic>, 2000</xref>) (<ext-link xlink:href="https://www.kazusa.or.jp/codon/" ext-link-type="uri">https://www.kazusa.or.jp/codon/</ext-link>) or by simply favouring codons ending in G or C. In any case, synonymous codons are scored against the respective GC target. For each site, one of the synonymous codons is selected with a likelihood corresponding to its score.</p>
    <p>To adjust ESE content, synonymous codons in the vicinity of the discarded introns (with vicinity being defined as up to 70 nucleotides) are tested for their ESE resemblance. This adds to the codons’ likelihood for being selected for a given position. In case the user opted to adjust only ESE resemblance but not GC content, there is no GC-based component to this likelihood. Testing codons for their ESE resemblance may optionally be expanded to all codons, including those in exon cores. Per default, all but the first intron are discarded. Optionally, the user may specify to remove the first intron, too. Testing a synonymous codon for its ESE resemblance is compatible with any of the above mentioned options to adjust GC content.</p>
    <p>Restriction sites are used to fine-tune which synonymous sites are inspected. Those sites that are part of a restriction enzyme the user wishes to retain are skipped while iterating through the sequence. Motifs that should be avoided are used as a blacklist against which a synonymous codon selected for its GC content/ESE resemblance is checked: if a pre-selected codon would introduce a motif on that list, the codon will not be used and the site will be left as is. For illustration of workflow, see <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1</xref>.</p>
    <p>The application generates a variant cloud in line with target GC content, ESE and restriction enzyme resemblance. It moves over the gene’s exonic sequence, inspecting one synonymous site at a time. A codon is retained or replaced by one of its synonymous alternatives based on the GC and/or ESE score it achieves. To ensure non-deterministic codon selection, codon scores are converted into a selection likelihood. At 6-fold degenerate sites all six synonymous codons are considered by default. The user can optionally adjust this behaviour such that only codons of the respective 2- or 4-codon sub-box are considered. Repeating this sliding window approach, the variant cloud gets populated. The variant best matching aforementioned targets is displayed on a results page. All other variants are available for download. Given that 50% of nucleotides in ESEs are A (25% G), highly GC rich sequences tend not to be commensurate with high ESE densities.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btac139_Supplementary_Data</label>
      <media xlink:href="btac139_supplementary_data.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>The authors thank Grzegorz Kudla and Christine Mordstein for feedback.</p>
    <sec>
      <title>Funding</title>
      <p>This work was supported by the European Research Council grant EvoGenMed [advanced grant ERC-2014-ADG 669207]. </p>
      <p><italic toggle="yes">Conflict of Interest</italic>: none declared. </p>
    </sec>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btac139-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Blencowe</surname><given-names>B.J.</given-names></string-name></person-group> (<year>2000</year>) <article-title>Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases</article-title>. <source>Trends Biochem. Sci</source>., <volume>25</volume>, <fpage>106</fpage>–<lpage>110</lpage>.<pub-id pub-id-type="pmid">10694877</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brinster</surname><given-names>R.L.</given-names></string-name></person-group>  <etal>et al</etal> (<year>1988</year>) <article-title>Introns increase transcriptional efficiency in transgenic mice</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>, <volume>85</volume>, <fpage>836</fpage>–<lpage>840</lpage>.<pub-id pub-id-type="pmid">3422466</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Caceres</surname><given-names>E.F.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2013</year>) <article-title>The evolution, impact and properties of exonic splice enhancers</article-title>. <source>Genome Biol</source>., <volume>14</volume>, <fpage>R143</fpage>.<pub-id pub-id-type="pmid">24359918</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fairbrother</surname><given-names>W.G.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2004a</year>) <article-title>Single nucleotide polymorphism-based validation of exonic splicing enhancers</article-title>. <source>PLoS Biol</source>., <volume>2</volume>, <fpage>E268</fpage>.<pub-id pub-id-type="pmid">15340491</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fairbrother</surname><given-names>W.G.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2004b</year>) <article-title>RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons</article-title>. <source>Nucleic Acids Res</source>., <volume>32</volume>, <fpage>W187</fpage>–<lpage>W190</lpage>.<pub-id pub-id-type="pmid">15215377</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goren</surname><given-names>A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2006</year>) <article-title>Comparative analysis identifies exonic splicing regulatory sequences—the complex definition of enhancers and silencers</article-title>. <source>Mol. Cell</source>, <volume>22</volume>, <fpage>769</fpage>–<lpage>781</lpage>.<pub-id pub-id-type="pmid">16793546</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ke</surname><given-names>S.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2011</year>) <article-title>Quantitative evaluation of all hexamers as exonic splicing elements</article-title>. <source>Genome Res</source>., <volume>21</volume>, <fpage>1360</fpage>–<lpage>1374</lpage>.<pub-id pub-id-type="pmid">21659425</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Le Hir</surname><given-names>H.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2003</year>) <article-title>How introns influence and enhance eukaryotic gene expression</article-title>. <source>Trends Biochem. Sci</source>., <volume>28</volume>, <fpage>215</fpage>–<lpage>220</lpage>.<pub-id pub-id-type="pmid">12713906</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mordstein</surname><given-names>C.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>Codon usage and splicing jointly influence mRNA localization</article-title>. <source>Cell Syst</source>., <volume>10</volume>, <fpage>351</fpage>–<lpage>362.e8</lpage>.<pub-id pub-id-type="pmid">32275854</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mordstein</surname><given-names>C.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021</year>) <article-title>Transcription, mRNA export, and immune evasion shape the codon usage of viruses</article-title>. <source>Genome Biol. Evol</source>., <volume>13</volume>, <fpage>evab106</fpage>.<pub-id pub-id-type="pmid">33988683</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nakamura</surname><given-names>Y.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2000</year>) <article-title>Codon usage tabulated from international DNA sequence databases: status for the year 2000</article-title>. <source>Nucleic Acids Res</source>., <volume>28</volume>, <fpage>292</fpage>.<pub-id pub-id-type="pmid">10592250</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Palazzo</surname><given-names>A.F.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2012</year>) <article-title>Nuclear export as a key arbiter of “mRNA identity” in eukaryotes</article-title>. <source>Biochim. Biophys. Acta</source>, <volume>1819</volume>, <fpage>566</fpage>–<lpage>577</lpage>.<pub-id pub-id-type="pmid">22248619</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Palazzo</surname><given-names>A.F.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021</year>) <article-title>GC-content biases in protein-coding genes act as an “mRNA identity” feature for nuclear export</article-title>. <source>Bioessays</source>, <volume>43</volume>, <fpage>e2000197</fpage>.<pub-id pub-id-type="pmid">33165929</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Parmley</surname><given-names>J.L.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2007</year>) <article-title>Splicing and the evolution of proteins in mammals</article-title>. <source>PLoS Biol</source>., <volume>5</volume>, <fpage>e14</fpage>.<pub-id pub-id-type="pmid">17298171</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Piovesan</surname><given-names>A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>Human protein-coding genes and gene feature statistics in 2019</article-title>. <source>BMC Res. Notes</source>, <volume>12</volume>, <fpage>315</fpage>.<pub-id pub-id-type="pmid">31164174</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Savisaar</surname><given-names>R.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2016</year>) <article-title>Purifying selection on exonic splice enhancers in intronless genes</article-title>. <source>Mol. Biol. Evol</source>., <volume>33</volume>, <fpage>1396</fpage>–<lpage>1418</lpage>.<pub-id pub-id-type="pmid">26802218</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Warnecke</surname><given-names>T.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2008</year>) <article-title>Finding exonic islands in a sea of non-coding sequence: splicing related constraints on protein composition and evolution are common in intron-rich genomes</article-title>. <source>Genome Biol</source>., <volume>9</volume>, <fpage>R29</fpage>.<pub-id pub-id-type="pmid">18257921</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname><given-names>X.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2015</year>) <article-title>Why selection might be stronger when populations are small: intron size and density predict within and between-species usage of exonic splice associated cis-motifs</article-title>. <source>Mol. Biol. Evol</source>., <volume>32</volume>, <fpage>1847</fpage>–<lpage>1861</lpage>.<pub-id pub-id-type="pmid">25771198</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>X.H.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2004</year>) <article-title>Computational definition of sequence motifs governing constitutive exon splicing</article-title>. <source>Genes Dev</source>., <volume>18</volume>, <fpage>1241</fpage>–<lpage>1250</lpage>.<pub-id pub-id-type="pmid">15145827</pub-id></mixed-citation>
    </ref>
    <ref id="btac139-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zuckerman</surname><given-names>B.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>Gene architecture and sequence composition underpin selective dependency of nuclear export of long RNAs on NXF1 and the TREX complex</article-title>. <source>Mol. Cell</source>, <volume>79</volume>, <fpage>251</fpage>–<lpage>267.e6</lpage>.<pub-id pub-id-type="pmid">32504555</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
